SynCardia Publishes 1st Brochure for Total Artificial Heart Patients & Their Caregivers
12-Page Resource Describes How the Total Artificial Heart Works, What to Expect Before & After Surgery and the Steps to Patient Discharge Using the Freedom® Driver
SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today the release of its first brochure for patients and caregivers about life with the SynCardia temporary Total Artificial Heart.
“By providing this brochure, we hope to address many of the common questions asked by patients and their families,” said Michael Garippa, SynCardia Chairman/CEO/President. ”Implanting the Total Artificial Heart isn’t just a medical decision made by surgeons; it is also a family decision made by patients with the help of their loved ones. We want them to feel confident when making this vital decision about their medical care and their lives”… read more